CryoSpray Ablation (TM) GI Patient Registry

Completed

Conditions studied: Barrett's Esophagus, Esophageal Cancer

In brief

The purpose of this study is to create a patient registry to collect and analyze post-510K approval information on subjects treated endoscopically with the CryoSpray Ablation™ System.

Key facts

Study ID

NCT00747448

Run by

CSA Medical, Inc.

People needed

199

Starts

2009-05-01

Expected to finish

2013-06-01

Last updated by the study team

2016-02-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• The study population consists of patients who are being treated, or were treated, with the CryoSpray Ablation™ System for malignant or pre-malignant conditions of the esophagus, including:
• Barrett's esophagus with or without dysplasia
• Squamous dysplasia of the esophagus
• Esophageal cancer, any stage

You may not qualify if…

• Subjects with esophageal lesions whose pathology was not one of the above.
• Subjects with one of the above conditions who were not treated with the CryoSpray Ablation™ System.

Where it is running

• The Scripps Research Institute — La Jolla, California, United States
• University of Maryland Medical Center — Baltimore, Maryland, United States
• Syosset Hospital — Lake Success, New York, United States
• University of North Carolina-Chapel Hill — Chapel Hill, North Carolina, United States
• Cleveland Clinic Foundation — Cleveland, Ohio, United States
• Rhode Island Hospital — Providence, Rhode Island, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.